The new results helped boost Moderna’s stock by more than 4% in early trading Monday, though the company’s shares are still down about 32% for the year. Moderna has more on the science behind mRNA.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week as the U.S.

Following its acquisition by Supernus Pharmaceuticals, Sage Therapeutics has let go of all of its remaining workforce, which ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

The Food and Drug Administration has recalled hundreds of blueberry boxes over possible contamination by Listeria.Almna Pak ...

Vaccine supply shortage comes at a bad time, as African countries make headway with their outbreaks and have seen good uptake ...

The National Association of County and City Health Officials (NACCHO) yesterday released its 2024 Forces of Change Survey ...